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Edited by Lukas HuberAbstract Sialylation of glycoconjugates is essential for mam-
malian cells. Sialic acid is synthesized in the cytosol from
N-acetylmannosamine by several consecutive steps. Using
N-propanoylmannosamine, a novel precursor of sialic acid, we
are able to incorporate unnatural sialic acids with a prolonged N-
acyl side chain (e.g., N-propanoylneuraminic acid) into glyco-
conjugates taking advance of the cellular sialylation machinery.
Here, we report that unnatural sialylation of HL60-cells leads to
an increased release of intracellular calcium after application of
thapsigargin, an inhibitor of SERCA Ca2þ-ATPases. Further-
more, this increased intracellular calcium concentration leads to
an increased adhesion to ﬁbronectin. Finally, we observed an
increase of the lectin galectin-3, a marker of monocytic
diﬀerentiation of HL60-cells.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Glycosylation represents the most common post-transla-
tional modiﬁcation of proteins. Glycans of glycoproteins are
synthesized in the Golgi apparatus by speciﬁc glyco-
syltransferases, which attach nucleotide-activated monosac-
charides to speciﬁc residues of glycoproteins. One terminal
monosaccharide of nearly all glycoproteins is sialic acid. The
most frequent sialic acid in humans is N-acetylneuraminic acid
(Neu5Ac). The physiological precursor of all sialic acids is N -
acetyl D-mannosamine (ManNAc). It has been shown that
synthetic N -acyl-modiﬁed D-mannosamines, such as N -pro-
panoyl D-mannosamine (ManNProp), can be taken up by cells
and eﬃciently metabolized to the respective N -acyl-modiﬁed
sialic acid in vitro and in vivo [1–4]. These synthetic, unnatural
sialic acid precursors are metabolized by the promiscuous sialic
acid biosynthetic pathway in the cytosol and are incorporated
into cell surface sialoglycoconjugates, where, depending on the
cell type, they replace 10–85% of normal, physiological sialic
acids (for review: [5]). This method of introducing novel, un-
physiological sialic acids into cellular glycoconjugates has been* Corresponding author. Fax: +49-30-8445-1541.
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(Fig. 1).
Application of ManNProp as sialic acid precursors to dif-
ferent biological systems has revealed important and unex-
pected functions of the N-acyl side chain of sialic acids, such as
stimulation of neural cells [6–8].
Sialic acids are involved in the diﬀerentiation and matura-
tion of lymphocytes [9,10]. Application of ManNProp leads to
an incorporation of Neu5Prop into human T-cells. These
biochemical engineered T-cells show increase in the peptidase-
activity of CD26 [11], a costimulator of lymphocytes. In
agreement with this, an incorporation of Neu5Prop into CD26
was observed [12]. Recently, we demonstrated that application
of HL60-cells with ManNProp activates the b1-integrins
(VLA4 or VLA5), resulting in an increased adhesion of HL60-
cells to ﬁbronectin [13].
Here, we report that application of ManNProp, e.g., in-
corporation of Neu5Prop into HL60-cells, leads to an in-
creased release of intracellular calcium in the presence of
thapsigargin, an inhibitor of SERCA Ca2þ-ATPases. Using
cell adhesion assays, we demonstrate that the increased
intracellular calcium concentration stimulates adhesion of
HL60-cells to ﬁbronectin. Finally, we measured an increase of
galectin-3 expression on protein level, a marker of monocytic
diﬀerentiation of HL60-cells.2. Materials and methods
2.1. Cell culture and antibodies
HL60 cells were propagated as suspension cultures in RPMI-1640
supplemented with 10% heat-inactivated fetal calf serum, 2 mM glu-
tamine, 100 U/ml penicillin, and 100 lg/ml streptomycin in an atmo-
sphere containing 5% CO2 at 37 C. Stock solutions of ManNAc or
ManNProp were prepared by dissolving the sugars in the medium. The
ﬁnal working concentration was 5 mM. Galectin-3 antibody was a gift
of Dr. R. Probstmeier (Bonn).
2.2. Sialic acid precursors
The physiological precursor for sialic acid (ManNAc was purchased
from Sigma). The synthetic derivative of sialic acid precursor ManN-
Prop was synthesized as described in [14].
2.3. Sialic acid quantiﬁcation
Sialic acid was quantiﬁed by the periodate/resorcinol method. In
brief, lysates from 20 106 cells were oxidized in 250 ll with 5 ll of
0.4 M periodic acid at 37 C for 90 min, followed by 15 min boiling in
500 ll of 6% resorcinol/2.5 mM CuSO4/44% HCl. After cooling for ablished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic representation of the incorporation of unnatural sialic acids into glycoproteins and structure of N -propanoylneuraminic acid. Note
that sialic acids are activated in the nucleus to the respective CMP-activated sialic acid. Activated sialic acids are then transported across the cytosol
into the golgi compartment, where speciﬁc sialiyltransferases are located.
100 R. Horstkorte et al. / FEBS Letters 571 (2004) 99–102few minutes, 500 ll tertbutyl alcohol was added, the samples were
vortexed and centrifuged for 5 min to precipitate cell debris. Imme-
diately after spinning, the supernatants were poured into OD cuvettes
and read at 630 nm. Sialic acid concentrations were calculated by
comparison with a standard curve (usually in a range of 0–250 lM
sialic acid) and expressed in nanomoles per mg protein.
2.4. Preparation of cell extracts
Cell pellets were solubilized at 4 C for 1 h in buﬀer containing
150 mM NaCl, 50 mM Tris, 1 mM CaCl2, 1 mM MgCl2, 1% Triton
and protease inhibitor cocktail (Sigma) at pH 7.4. Cell extracts were
centrifuged at 13 000 rpm for 30 min and supernatants were collected.
Protein concentration was determined in 96-well ELISA plates using
200 ll bicinchonic acid protein reagent (Pierce) and a 50 ll sample.
Plates were evaluated in a 96-well ELISA reader (Spectra) at 570 nm.
2.5. Immunoblotting
Samples (150 lg/lane) were separated on SDS-polyacrylamide gels
(BioRad) and transferred to nitrocellulose ﬁlters. Equal loading was
controlled by actin staining (data not shown). The blots were blocked
with 4% fat-free dried milk powder in PBS, incubated with the re-
spective primary antibodies, washed with PBS and incubated with the
appropriate secondary antibodies conjugated with peroxidase. After
washing, proteins were detected by enhanced chemiluminescence
(Amersham) according to the manufacturer’s instructions, and visu-
alized by exposing the blots to a Fuji imager system (LAS) for time
periods between 10 and 120 s.
2.6. Cell adhesion assay
For adhesion assays, 96-well plates were coated with ﬁbronectin
(10 lg/ml) for 16 h at 4 C. Unspeciﬁc binding was blocked with 1%
BSA for 4 h at 4 C. Cells were incubated with serum-free medium for
2 h before the experiment. 3 104 cells in 100 ll were plated per well.
After 1 h of incubation at 37 C, unattached cells were rinsed away and
attached cells were quantiﬁed using a cell adhesion quantiﬁcation kit
(Ampliﬁcon) according to the manufacturer’s instructions.
2.7. Calcium measurements
Cells were cultivated for 48 h in the absence or presence of 10 mM
ManNAc or ManNProp, respectively. 5 105 ml1 cells were incu-
bated with 1 ll Fluo-3 reagent (Molecular Probes) for 30 min at 37 C.
Cells were washed in indicator-free RPMI-medium (Biochrome) and
incubated again for 30 min at 37 C. Fluorescence was analyzed on aFACS-Vantage (Becton–Dickinson). The non-ratiometric Ca2þ indi-
cator, ﬂuo-3, was used to provide information about changes in rela-
tive calcium concentrations. Fluo-3 was excited at 488 nm with an
argon laser and the ﬂuorescence was measured at an emission wave-
length above 510 nm. Acquisition of the ﬂuorescence data and image
analysis were performed using CellQuest (Becton–Dickinson) and
standard PC evaluation software.
Maximal ﬂuorescence intensity was calculated after application of
1 lg/ml ionomycin (Sigma), background ﬂuorescence was calculated in
the presence of 5 mM EGTA. Thapsigargin (Sigma) was used at
100 nM.3. Results and discussion
3.1. ManNProp does not increase total sialylation in HL60-cells
HL60-cells have been demonstrated to metabolize ManN-
Prop to Neu5Prop and express this on their cell surface [15]. In
a ﬁrst set of experiments, we quantiﬁed the total sialic acids of
HL60-cells cultured in the absence and presence of ManNAc
(the physiological precursor of sialic acid) or ManNProp, re-
spectively. As shown in Fig. 2, neither addition of ManNAc
nor addition of ManNProp could increase the total amount of
sialic acid in HL60-cells. In all cases, we measured approxi-
mately 30 nmol sialic acid per mg cellular protein (Fig. 2).
This is of special interest, because HL60-cells metabolize
both ManNAc and ManNProp to the corresponding sialic
acid. After application of ManNProp, 20% of Neu5Ac is re-
placed by Neu5Prop (data not shown and [15]). The fact that
the total concentration of sialic acids did not increase after
application of ManNAc or ManNProp suggests a cellular
regulation and upper limit of the total amount of sialic acids.
3.2. ManNProp modulates the release of Ca2þ from
intracellular stores
Recently, we could demonstrate that application of
ManNProp leads to an increased adhesion of HL60-cells to
ﬁbronectin [13]. This increased adhesion is mediated by
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Fig. 2. Quantiﬁcation of total sialic acid. HL60-cells were cultured in
the absence or presence of 5 mM ManNAc or ManNProp for 48 h,
respectively. Total sialic acids were quantiﬁed using the periodate/
resorcinol assay. Bars represent mean values of three independent
experiments.
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requiring enzymes, such as calpain, which regulates cluster
formation of leukocyte integrins (for review see: [16]), we
measured the intracelluar Ca2þ-concentration of HL60-cells
cultured in the presence or absence of ManNAc or ManNProp
(Fig. 3). When cells were cultured in the presence of ManN-
Prop and extracellular Ca2þ was removed by EGTA, we ob-
served a slightly higher intracellular Ca2þ-concentration
(Fig. 3 EGTA). As a control, intracellular Ca2þ-concentration
was measured in the presence of ionomycin. No diﬀerencetime (s)
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Fig. 3. Calcium signals. HL60-cells were cultured in the absence or presenc
loaded with ﬂuo-3 and analyzed for intracellular calcium concentration in
Becton–Dickinson FACScan instrument. EGTA, ionomycin or thapsigargin
independent experiments.could be observed after application of the Ca2þ-ionophore
ionomycin, which is used to obtain maximal intracellular
Ca2þ-concentration, when cells were cultivated in the absence
or presence of ManNAc or ManNProp (Fig. 3 Ionomycin).
However, when HL60-cells were cultured in the presence of
ManNProp, application of thapsigargin, an inhibitor of
SERCA Ca2þ-ATPases, which transport Ca2þ-ions from the
cytosol to intracellular stores, a dramatic increase of intracel-
lular Ca2þ-concentration was observed (Fig. 3, thapsigargin).
Since application of ManNProp interferes with the transport
of Ca2þ into the ER lumen, it can be postulated that ManN-
Prop, e.g., incorporation of Neu5Prop, interferes with multiple
cellular signaling cascades.
3.3. Application of thapsigargin increases the adhesion of
HL60-cells to ﬁbronectin after incorporation of Neu5Prop
In order to investigate whether the increased Ca2þ-concen-
tration after application of thapsigargin in Neu5Prop-modiﬁed
cells has functional consequences, we performed cell adhesion
assays on ﬁbronectin substrates. HL60-cells were treated with
ManNAc or ManNProp and allowed to adhere to ﬁbronectin
in the absence or presence of thapsigargin (Fig. 4). HL60-cells
did not adhere to ﬁbronectin in unstimulated status of b1-in-
tegrins (Fig. 4, no addition). As a positive control, cells were
incubated with the phorbolester PMA known to activate in-
tegrin-mediated adhesion of HL60-cells to ﬁbronectin [13].
When stimulated with PMA, HL60-cell adhered to ﬁbronectin,
no matter whether modiﬁed with Neu5Prop or not. However,
when HL60-cells were incubated with thapsigargin, we
observed a 50% increase in adhesion only in the case ofIonomycin
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the presence of EGTA, ionomycin or thapsigargin, respectively, on a
were added after 100 s (arrow). Curves represent mean values of three
no addition PMA Thapsigargin
-30
0
30
60
90
120
150
re
l. 
ad
he
sio
n
control
ManNAc
ManProp
*
Fig. 4. Adhesion of HL60-cells to ﬁbronectin. HL60-cells were grown
in the absence or presence of 5 mM ManNAc or ManNProp for 48 h,
respectively. Cells were allowed to adhere to ﬁbronectin coated 96-well
plates for 1 h in the presence of 1 nM PMA or 100 nM thapsigargin.
Data were obtained from three independent experiments carried out in
triplicates.
102 R. Horstkorte et al. / FEBS Letters 571 (2004) 99–102ManNProp-treated cultures (Fig. 4, thapsigargin). These data
ﬁt were to the Ca2þ-concentration measurements shown in
Fig. 3.
3.4. ManNProp induces increased expression of galectin-3
HL60-cells are a well-known cellular system to analyze
myeloid cell diﬀerentiation. It has been shown recently that
expression of speciﬁc galectins describes the status of the dif-
ferentiation of HL60-cells. PMA is known to promote
monocytic diﬀerentiation, which goes in parallel with increased
expression of galectin-3 [17]. We therefore analyzed expression
of galectins in HL60-cells cultured in the absence or presence
of ManNProp. No change in the expression of galectin-9 or
galectin-10 could be detected (data not shown). However, after
application of ManNProp expression of galectin-3 was up-Fig. 5. Expression of galectin-3. (A) HL60-cells grown in the absence
(control) or presence (ManNProp) of 5 mM ManNProp for 48 h. Cell
solubilisates were analyzed by Western blot using galectin-3-speciﬁc
antibodies. One out of two Western blots is shown. (B) Quantiﬁcation
of the representative Western blot shown in (A).regulated by 66% (Fig. 5). Since galectin-3 is a marker for
monocytic diﬀerentiation of HL60-cells, we conclude that
ManNProp, e.g., biochemical engineering of the N -acyl side
chain of neuraminic acid leads to monocytic diﬀerentiation.
This is further supported by the increased adhesion of
ManNProp-treated HL60-cells to ﬁbronectin.
Taken together, we proposed that the N-acyl side chain of
neuraminic acid modulates the function of the SERCA Ca2þ-
ATPases. The fact that thapsigargin increases intracellular
Ca2þ-concentration only after application of ManNProp raises
the question of how ManNProp or Neu5Prop is able to
modulate the function of SERCA Ca2þ-ATPases. SERCA
Ca2þ-ATPases belong together with Naþ-ATPases to the P-
type ATPase family (for review see: [18]). Naþ-ATPases are
heterodimers consisting of an alpha and beta subunit (for re-
view see: [18]). The beta subunit is highly glycosylated and
removal of all carbohydrate structures results in the complete
loss of enzymatic activity [19]. Since also SERCA Ca2þ-pumps
have several potential N-glycosylation sites, it is possible that
incorporation of Neu5Prop in SERCA Ca2þ-pumps interferes
with its function.
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